Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial - Concepedia

Concepedia

Publication | Closed Access

Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial

195

Citations

31

References

2017

Year

J. Andrew Bird, Jonathan M. Spergel, Stacie M. Jones, Rima Rachid, Amal Assa’ad, Julie Wang, Stephanie A. Leonard, Susan Laubach, Edwin Kim, Brian P. Vickery,

The Journal of Allergy and Clinical Immunology In Practice

References

	Year	Citations

Page 1